Regeneron Extends BARDA Ebola Treatment Supply Deal by About $270 Million
Regeneron extended its Ebola treatment supply deal with BARDA, adding about $270 million.
Story updates
11:37:13 AM UTC
SquawkNews
By Adriano MarcheseRegeneron Pharmaceuticals extended its supply agreement with the U.S. government to provide additional doses of its Ebola treatment through 2031 in a deal worth about $270 million.The renewed contract is with the Biomedical Advanced Research and Development Authority, or Barda, w…